Rutgers, July 21/22, 2014
Join the TTS North America summit with biotech and healthcare sector innovation leaders from research, tech transfer, start-ups, VC, pharma, banking, patient organizations, government and industry.
GUV has secured a special “2-4-1” registration offer available to all our clients that provides “at cost” access to this Summit. See below and reserve now!
21-22 July, 2014 at Rutgers, New Jersey, USA
With a truly interactive setup, the TTS North America allows all participants to hear from and meet with leading personnel from stakeholder groups throughout the healthcare / life science sector. Close-up and personal you will have the opportunity to interact and engage with those that can reinvigorate your business strategy.
Debate and deliberation of the key issues and challenges in our sector today is core to the TTS Global Initiative mission statement. We aim to create an environment where you can ultimately instigate real-time business.
Register now with our 2-4-1 offer (pay for one person at either the academic or industry rate, and contact TTS directly on the email addresses below to receive an additional VIP pass completely free).
Confirmed key stakeholder groups include:
NIH
NSF
Institut Pasteur
John’s Hopkins Medical School
Sanofi
Boehringer-Ingelheim
AstraZeneca
Merck
Abbvie
Celgene
Needham&Co
Broadview Ventures
Synthesis Capital (Advent Healthcare)
JDRF Epilepsy Foundation
MRC Technology
Cornell
Rockefeller
Rutgers
Boston University
UCSF
Venture Valuation
Patent Docs
PwC
Do not miss this opportunity! 2-4-1 access! Any queries, please contact either Morris S Berrie or Christian J Suojanen
